Skip to main content

What impact will Brexit have on the NHS and universities?

I spoke recently at a Public Policy Exchange Symposium on the topic of ‘Brexit: What impact will it have on the NHS and universities?” The event was chaired by Dr Philippa Whitford MP. In my presentation, I outlined how Brexit will lead to major challenges for the UK’s NHS and universities, as well as for public health and the life sciences industry in the UK.

For the NHS, key issues include the retention of NHS employees from other EU countries; and the future recruitment of health professionals after the UK leaves the EU. The NHS will need to implement policies to train considerably more health professionals (including doctors) and retain them in the workforce. Another key issue is the right to publicly-funded healthcare of the EU nationals living in the UK and the UK nationals living in other EU countries. The future of the EHIC card also needs to be determined.

For public health, a key issue will be how the UK participates in future EU-wide public health initiatives. These cover many areas including food regulations, road safety, air pollution, tobacco control, and chemical hazards; and are important when dealing with cross-national issues (e.g. air pollution) or with large multi-national corporations.

There are also uncertainties for the wider health economy including the future location of the European Medicines Agency and the risk that the UK may become less-favoured as a site for commercially supported clinical research.

For universities, there will be a loss of research funding from the EU, less scope to recruit academic staff from other EU countries and threats to our future participation in the ERASMUS Student Mobility Programme. We also need to consider if and how we continue to take part in the Bologna Process (agreements between EU countries to ensure comparability in the standards and quality of higher education qualifications). Linked to this is a risk that students from the EU may be less likely to apply to study at UK universities, particularly if their fees increase to the level paid by overseas students.

In conclusion, Brexit will have important impacts on the NHS and the UK’s universities. Most impacts appear to be negative. It's important that the NHS and universities engage with government to ameliorate these risks and also gain public support (e.g. to reinforce that immigration has positive benefits).

A copy of my presentation can be viewed on Slideshare.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.